Adoptive T Regulatory Cell Therapy for Tolerance Induction
There is a clear need to develop strategies to induce tolerance without the need of chronic immunosuppression in transplant recipient and in patients with autoimmunity. Adoptive T regulatory cell (Treg) therapy offers the potential of long-lasting protection. However, based on results of clinical trials so far with ex vivo expanded autologous Tregs in type 1 diabetic (T1D) patients, it seems unlikely that single immunotherapy with Treg infusion without immunomodulation regimens that promote stable donor Treg engraftment and persistence would afford truly significant clinical benefit. Combination therapies could provide improved outcomes with consideration of the fundamental factors required for Treg generation, homeostasis, and function to promote long-term donor Treg persistence to provoke beneficial therapeutic outcomes.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Current transplantation reports - 2(2015), 2 vom: 01. Juni, Seite 191-201 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cabello-Kindelan, Cecilia [VerfasserIn] |
|---|
| Themen: |
IL-2 |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM248660535 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM248660535 | ||
| 003 | DE-627 | ||
| 005 | 20231224151905.0 | ||
| 007 | tu | ||
| 008 | 231224s2015 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0828.xml |
| 035 | |a (DE-627)NLM248660535 | ||
| 035 | |a (NLM)25938011 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cabello-Kindelan, Cecilia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adoptive T Regulatory Cell Therapy for Tolerance Induction |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a There is a clear need to develop strategies to induce tolerance without the need of chronic immunosuppression in transplant recipient and in patients with autoimmunity. Adoptive T regulatory cell (Treg) therapy offers the potential of long-lasting protection. However, based on results of clinical trials so far with ex vivo expanded autologous Tregs in type 1 diabetic (T1D) patients, it seems unlikely that single immunotherapy with Treg infusion without immunomodulation regimens that promote stable donor Treg engraftment and persistence would afford truly significant clinical benefit. Combination therapies could provide improved outcomes with consideration of the fundamental factors required for Treg generation, homeostasis, and function to promote long-term donor Treg persistence to provoke beneficial therapeutic outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a IL-2 | |
| 650 | 4 | |a T regulatory cells | |
| 650 | 4 | |a T-cells | |
| 650 | 4 | |a tolerance | |
| 650 | 4 | |a transplantation | |
| 700 | 1 | |a Mackey, Shane |e verfasserin |4 aut | |
| 700 | 1 | |a Bayer, Allison L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current transplantation reports |d 2014 |g 2(2015), 2 vom: 01. Juni, Seite 191-201 |w (DE-627)NLM235939315 |x 2196-3029 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2015 |g number:2 |g day:01 |g month:06 |g pages:191-201 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2015 |e 2 |b 01 |c 06 |h 191-201 | ||